Completed NA INTERVENTIONAL 2-arm NCT02001428

Malaria in Early Life Study

Intermittent Screening and Treatment for the Control of Malaria in the First Year of Life in Papua, Indonesia: A Cluster Randomized Controlled Trial

Sponsor: Eijkman Institute for Molecular Biology

Conditions Plasmodium Falciparum Malaria Plasmodium Vivax Malaria

Interventions dihydroartemisinin-piperaquine

Updated 8 times since 2017 Last updated: Jul 31, 2018 Started: Jul 21, 2014 Primary completion: Mar 31, 2016 Completion: May 17, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02001428, this NA trial focuses on Plasmodium Falciparum Malaria and Plasmodium Vivax Malaria and remains completed. Sponsored by Eijkman Institute for Molecular Biology, it has been updated 8 times since 2014, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2019 — Jan 2021 [monthly]

Completed NA
Sep 2018 — Nov 2019 [monthly]

Completed NA

Status: Unknown Status → Completed

▶ Show 3 earlier versions

Jun 2018 — Sep 2018 [monthly]

Unknown Status NA
Mar 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — Mar 2018 [monthly]

Recruiting NA

First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eijkman Institute for Molecular Biology
Gadjah Mada University
Menzies School of Health Research
Timika Research Facility, Indonesia

Data source: Gadjah Mada University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Timika, Indonesia